menu
    • menu

    Company profile for Xilio Therapeutics

    NEW Drugs in Dev: 5
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engine...
    Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. To learn more, please visit www.xiliotx.com.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Xilio TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    828 Winter St, Waltham, Massachusetts 02451
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xiliotx.com/index.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xilio-tx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xilio Therapeutics Reports Q1 2026 Results, Pipeline Updates
    Xilio Therapeutics Reports Q1 2026 Results, Pipeline Updates

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3292720/0/en/xilio-therapeutics-reports-first-quarter-2026-financial-results-and-provides-pipeline-and-business-updates.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Xilio Therapeutics Reports Inducement Grants Under Nasdaq Rule
    Xilio Therapeutics Reports Inducement Grants Under Nasdaq Rule

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3290653/0/en/xilio-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Xilio Therapeutics to Present XTX601 Data at the AACR Meeting
    Xilio Therapeutics to Present XTX601 Data at the AACR Meeting

    17 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7184525

    FIRSTWORD PHARMA
    17 Apr 2026
    Share Share
    Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D., to Board
    Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D., to Board

    16 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/16/3275223/0/en/Xilio-Therapeutics-Appoints-Cheryl-R-Blanchard-Ph-D-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    16 Apr 2026
    Share Share
    Xilio Therapeutics Announces Inducement Grants Under Nasdaq Rules
    Xilio Therapeutics Announces Inducement Grants Under Nasdaq Rules

    03 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/03/3268141/0/en/Xilio-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    03 Apr 2026
    Share Share
    Xilio Reveals Pipeline Progress And 2025 Financial Results
    Xilio Reveals Pipeline Progress And 2025 Financial Results

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260273/0/en/Xilio-Therapeutics-Announces-Pipeline-and-Business-Updates-and-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search